Table: Sapporo Clinical Lab -2016/17 group results

Sapporo Clinical Laboratory

12/05/2017 07:30

May 12 (Reuters)-  
          Sapporo Clinical Laboratory Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           17.06           17.53          17.70         8.66     
               (-2.7 pct)      (+2.1 pct)     (+3.8 pct)    (+2.6 pct)  
  Operating      771 mln         974 mln        751 mln      338 mln    
               (-20.8 pct)     (+12.0 pct)    (-2.6 pct)    (-3.5 pct)  
  Recurring      803 mln         999 mln        778 mln      353 mln    
               (-19.6 pct)     (+11.5 pct)    (-3.1 pct)    (-4.5 pct)  
  Net 
  Net            513 mln         590 mln        522 mln      237 mln    
               (-13.0 pct)     (+3.0 pct)     (+1.8 pct)    (-1.0 pct)  
  EPS          147.69 yen      169.72 yen     150.28 yen    68.12 yen   
  Ann Div       10.00 yen       11.00 yen      10.00 yen                
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div       10.00 yen       11.00 yen      10.00 yen                
   
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T 
  ((Tokyo Headline News Desk +813 6441 1812))